Cargando…

COVID-19 and Cancer in Cuba

The COVID-19 pandemic has called attention to the contribution of comorbidities, including cancer and brought additional challenges to previously existing programs for cancer treatment and control. The COVID-19 pandemic in Cuba was addressed through an integrated all-society action plan that to date...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubio, Maria Caridad, Sanchez, Lizet, Abreu-Ruíz, Gisela, Bermejo-Bencomo, Walkiria, Crombet, Tania, Lage, Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413158/
https://www.ncbi.nlm.nih.gov/pubmed/32994047
http://dx.doi.org/10.1053/j.seminoncol.2020.07.009
_version_ 1783568750999502848
author Rubio, Maria Caridad
Sanchez, Lizet
Abreu-Ruíz, Gisela
Bermejo-Bencomo, Walkiria
Crombet, Tania
Lage, Agustin
author_facet Rubio, Maria Caridad
Sanchez, Lizet
Abreu-Ruíz, Gisela
Bermejo-Bencomo, Walkiria
Crombet, Tania
Lage, Agustin
author_sort Rubio, Maria Caridad
collection PubMed
description The COVID-19 pandemic has called attention to the contribution of comorbidities, including cancer and brought additional challenges to previously existing programs for cancer treatment and control. The COVID-19 pandemic in Cuba was addressed through an integrated all-society action plan that to date has been largely successful with a low incidence of COVID-19 and mortality rates several-fold lower than worldwide averages. Despite downsizing many other health components all oncology services were maintained. Between March 11, when the first case was detected, until July 23, Cuba reported 2,449 cases of COVID-19 that included 28 (1.14%) with a diagnosis of cancer. Distribution among cancer diagnoses did not deviate from that expected according to cancer epidemiology in Cuba. However, although the probability of getting infected with the coronavirus for a cancer patient (0.012%), was not higher than that of the general population (0.020%), 9 of the 28 (32.1%) died, a lethality higher than that of COVID-19 patients without cancer (3.5%) a difference that is statistically significant (P< .001). We argue that going forward scientific research on the relationship of aging, inflammation and cancer, including identification of biomarkers and the development of novel therapeutic interventions, should become one of the priorities in the post-COVID agenda of both oncologists and infectious disease scientists.
format Online
Article
Text
id pubmed-7413158
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74131582020-08-10 COVID-19 and Cancer in Cuba Rubio, Maria Caridad Sanchez, Lizet Abreu-Ruíz, Gisela Bermejo-Bencomo, Walkiria Crombet, Tania Lage, Agustin Semin Oncol Article The COVID-19 pandemic has called attention to the contribution of comorbidities, including cancer and brought additional challenges to previously existing programs for cancer treatment and control. The COVID-19 pandemic in Cuba was addressed through an integrated all-society action plan that to date has been largely successful with a low incidence of COVID-19 and mortality rates several-fold lower than worldwide averages. Despite downsizing many other health components all oncology services were maintained. Between March 11, when the first case was detected, until July 23, Cuba reported 2,449 cases of COVID-19 that included 28 (1.14%) with a diagnosis of cancer. Distribution among cancer diagnoses did not deviate from that expected according to cancer epidemiology in Cuba. However, although the probability of getting infected with the coronavirus for a cancer patient (0.012%), was not higher than that of the general population (0.020%), 9 of the 28 (32.1%) died, a lethality higher than that of COVID-19 patients without cancer (3.5%) a difference that is statistically significant (P< .001). We argue that going forward scientific research on the relationship of aging, inflammation and cancer, including identification of biomarkers and the development of novel therapeutic interventions, should become one of the priorities in the post-COVID agenda of both oncologists and infectious disease scientists. Published by Elsevier Inc. 2020-10 2020-08-07 /pmc/articles/PMC7413158/ /pubmed/32994047 http://dx.doi.org/10.1053/j.seminoncol.2020.07.009 Text en © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rubio, Maria Caridad
Sanchez, Lizet
Abreu-Ruíz, Gisela
Bermejo-Bencomo, Walkiria
Crombet, Tania
Lage, Agustin
COVID-19 and Cancer in Cuba
title COVID-19 and Cancer in Cuba
title_full COVID-19 and Cancer in Cuba
title_fullStr COVID-19 and Cancer in Cuba
title_full_unstemmed COVID-19 and Cancer in Cuba
title_short COVID-19 and Cancer in Cuba
title_sort covid-19 and cancer in cuba
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413158/
https://www.ncbi.nlm.nih.gov/pubmed/32994047
http://dx.doi.org/10.1053/j.seminoncol.2020.07.009
work_keys_str_mv AT rubiomariacaridad covid19andcancerincuba
AT sanchezlizet covid19andcancerincuba
AT abreuruizgisela covid19andcancerincuba
AT bermejobencomowalkiria covid19andcancerincuba
AT crombettania covid19andcancerincuba
AT lageagustin covid19andcancerincuba